{"id":273037,"date":"2026-09-28T09:56:22","date_gmt":"2026-09-28T04:26:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=273037"},"modified":"2026-09-28T09:56:22","modified_gmt":"2026-09-28T04:26:22","slug":"why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/","title":{"rendered":"Syncom Formulations (India) Ltd. (SYNCOMF) Share Price Rises 14.61% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-india-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF)<\/a> share price rose to Rs 22.99 today, up 14.61% from the previous close. Market cap was Rs 1,885.64 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 28 September 2026 at 9:54:03 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Syncom Formulations Share Price rose to Rs 22.99 today, up 14.61%, with market capitalisation at Rs 1,885.64 crore. The move places Syncom Formulations (India) Ltd. in focus in today&#8217;s share market today, even as the supplied data does not establish a company-specific catalyst.<\/p>\n<p>Syncom Formulations Share Price is in the spotlight after the stock rose 14.61% to Rs 22.99 on 28 September 2026, against a previous close of Rs 20.06. The session opened at Rs 20.06, touched a day high of Rs 23.03 and a day low of Rs 20.06, while turnover stood at Rs 4.93 crore and market capitalisation at Rs 1,885.64 crore. On the available data, the price rise is clear, but a company-specific catalyst is not established. For readers tracking Syncom Formulations Share Price Today, the factual trigger is the day&#8217;s move itself, along with the company&#8217;s valuation and healthcare sector context. Univest notes that the stock now ranks among the stocks in news on this session based on price action alone.<\/p>\n<p>In Syncom Formulations Share Price news, the focus is on what changed today rather than on any unverified explanation. The stock&#8217;s rise from Rs 20.06 to Rs 22.99 adds Rs 2.93 per share in one session. That makes the move relevant for investors watching Syncom Formulations Share Price Live, because the update can be read directly from the price, market cap and turnover figures supplied. Univest keeps the discussion grounded in verified numbers so the article stays useful for stock analysis, fundamental analysis and market update tracking.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\" title=\"Syncom Formulations Share Price Today: Price Action Analysis\">Syncom Formulations Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\" title=\"Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis\">Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Why_Investors_Are_Watching_Syncom_Formulations\" title=\"Why Investors Are Watching Syncom Formulations\">Why Investors Are Watching Syncom Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#About_Syncom_Formulations_India_Ltd\" title=\"About Syncom Formulations (India) Ltd.\">About Syncom Formulations (India) Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Track_Syncom_Formulations_Share_Price_on_Univest\" title=\"Track Syncom Formulations Share Price on Univest\">Track Syncom Formulations Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Why_did_Syncom_Formulations_Share_Price_rise_today\" title=\"Why did Syncom Formulations Share Price rise today?\">Why did Syncom Formulations Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#What_is_Syncom_Formulations_Share_Price_today\" title=\"What is Syncom Formulations Share Price today?\">What is Syncom Formulations Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#What_is_the_market_cap_of_Syncom_Formulations\" title=\"What is the market cap of Syncom Formulations?\">What is the market cap of Syncom Formulations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#How_is_Syncom_Formulations_valued_on_earnings_and_book_value\" title=\"How is Syncom Formulations valued on earnings and book value?\">How is Syncom Formulations valued on earnings and book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#What_do_ROE_and_ROCE_show_for_Syncom_Formulations\" title=\"What do ROE and ROCE show for Syncom Formulations?\">What do ROE and ROCE show for Syncom Formulations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#How_does_Syncom_Formulations_compare_with_peers\" title=\"How does Syncom Formulations compare with peers?\">How does Syncom Formulations compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#What_is_the_dividend_yield_for_Syncom_Formulations\" title=\"What is the dividend yield for Syncom Formulations?\">What is the dividend yield for Syncom Formulations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-28\/#Should_investors_track_Syncom_Formulations_Share_Price_on_Univest\" title=\"Should investors track Syncom Formulations Share Price on Univest?\">Should investors track Syncom Formulations Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Syncom Formulations Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.93 (+14.61%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.93 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 22.99 from the previous close of Rs 20.06, a move of Rs 2.93 or 14.61%. The stock opened at Rs 20.06, reached a high of Rs 23.03, recorded a low of Rs 20.06.<\/p>\n<p>Syncom Formulations Share Price Today shows a clean same-day gain of Rs 2.93, or 14.61%, with the stock closing at Rs 22.99 after opening at Rs 20.06. The intraday range was tight around the opening level, with a day high of Rs 23.03 and a day low of Rs 20.06. The session&#8217;s turnover was Rs 4.93 crore, which records the traded value for the day. This is the factual price action for Syncom Formulations Share Price, and it confirms a sharp upward move without adding an unverified cause. Univest presents the move as a price rise in the context of today&#8217;s stock news, not as a forecast or rating.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\"><\/span><strong>Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.91<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.5%<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P\/E 22.05x, P\/B 4.29x, ROE 20.19%, ROCE 26.8%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 22.05x, P\/B at 4.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 732.57 crore<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 22.05x, which is below the benchmark median of 32.87x, a difference of -32.92%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.48%, a difference of +75.87%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.17%, a difference of +103.49%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 22.05x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Syncom_Formulations\"><\/span><strong>Why Investors Are Watching Syncom Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Syncom Formulations Share Price rose 14.61% today to Rs 22.99.<\/li>\n<li>The stock moved up Rs 2.93 from the previous close of Rs 20.06.<\/li>\n<li>Market capitalisation stands at Rs 1,885.64 crore.<\/li>\n<li>P\/E is 22.05, P\/B is 4.29, ROE is 20.19% and ROCE is 26.80%.<\/li>\n<li>In the same industry benchmark, the company&#8217;s P\/E is below the median of 32.87 and its ROE and ROCE are above the median levels.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Syncom_Formulations_India_Ltd\"><\/span><strong>About Syncom Formulations (India) Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Syncom Formulations (India) Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company description supplied in the data is limited, so the reliable framing here is based on its listed industry and the financial metrics attached to the stock. As a pharmaceuticals business, it belongs to a segment where investors often compare valuation, profitability and market capitalisation against other domestic listed peers. The current data shows Syncom Formulations with a market cap of Rs 1,885.64 crore, a P\/E of 22.05 and a P\/B of 4.29, which makes its stock performance relevant not just for today&#8217;s price rise but also for wider company overview and financial analysis reading. Univest uses these figures to help readers place the company within the Indian stock market healthcare universe.<\/p>\n<p>The share price movement today does not change the business description, but it does bring Syncom Formulations Share Price back into focus for readers tracking stock updates, company news and market update articles. When new company-specific information arrives, the same stock page can be used to review the next move in context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Syncom_Formulations_Share_Price_on_Univest\"><\/span><strong>Track Syncom Formulations Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-india-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>You can track Syncom Formulations Share Price on Univest for live share price updates, stock news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Syncom Formulations Stock News, Syncom Formulations Share Price Today and broader Syncom Formulations Stock Analysis in one place, so the current move can be compared with future updates using the same verified market data.<\/p>\n<p>For investors who follow market news and share market today developments, the stock page is a practical way to keep Syncom Formulations Share Price under review alongside financial results, peer comparison and sector analysis. Univest presents the figures in a structured format so the reader can return when fresh stock updates appear.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Syncom_Formulations_Share_Price_rise_today\"><\/span><strong>Why did Syncom Formulations Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a 14.61% rise to Rs 22.99, but it does not establish a company-specific catalyst. The move is visible in today&#39;s price action, previous close, open, high, low and turnover figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_Share_Price_today\"><\/span><strong>What is Syncom Formulations Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price today is Rs 22.99. It gained Rs 2.93, or 14.61%, from the previous close of Rs 20.06 and closed near the session high of Rs 23.03.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Syncom_Formulations\"><\/span><strong>What is the market cap of Syncom Formulations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Syncom Formulations is Rs 1,885.64 crore. That figure places the company above the same-industry median market cap of Rs 732.57 crore, based on the supplied benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Syncom_Formulations_valued_on_earnings_and_book_value\"><\/span><strong>How is Syncom Formulations valued on earnings and book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations has a P\/E ratio of 22.05 and a P\/B ratio of 4.29. Its EPS is Rs 0.91 and book value is Rs 4.68, giving readers a direct valuation reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Syncom_Formulations\"><\/span><strong>What do ROE and ROCE show for Syncom Formulations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 20.19% and ROCE is 26.80%. These figures indicate the company&#39;s reported profitability and capital efficiency, and both sit above the same-industry median and average levels supplied in the benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_compare_with_peers\"><\/span><strong>How does Syncom Formulations compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Compared with listed peers in pharmaceuticals, Syncom Formulations has a lower P\/E than Sun Pharma, Divi&#39;s Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are also competitive against several of the supplied peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_dividend_yield_for_Syncom_Formulations\"><\/span><strong>What is the dividend yield for Syncom Formulations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations has a dividend yield of 0.5%. This is a factual yield measure based on the supplied data and should be read alongside the current share price and other valuation ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Syncom_Formulations_Share_Price_on_Univest\"><\/span><strong>Should investors track Syncom Formulations Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors tracking Syncom Formulations Share Price can use Univest to monitor live price updates, fundamentals, shareholding pattern and sector context. The platform keeps the stock page aligned with verified market data and related stock news.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Syncom Formulations (India) Ltd. Share Price rises to Rs 22.99. marking a 14.61% rise today. Market cap stands at Rs 1,885.64 crore.<\/p>\n","protected":false},"author":29,"featured_media":273036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-273037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["273036"],"rank_math_title":["Syncom Formulations Share Price Rise and Valuation View"],"rank_math_description":["Syncom Formulations Share Price rose 14.61% to Rs 22.99. Read the price action, valuation, fundamentals, sector context and peer comparison."],"rank_math_focus_keyword":["Syncom Formulations Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/syncom-formulations-india-ltd-syncomf-share-price-rises-14-61-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=273037"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273037\/revisions"}],"predecessor-version":[{"id":273038,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273037\/revisions\/273038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/273036"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=273037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=273037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=273037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}